Cannabis
Cannafornia CBD and UFC Fighter Colby Covington Join Forces
Welterweight title contender Colby Covington signs endorsement deal with Cannafornia CBD ahead of his August 3rd UFC on ESPN Main Event Fight.
American UFC star Colby Covington signed an endorsement deal earlier this week with Cannafornia CBD, the sports performance focused division of Cannafornia. The UFC fighter recently posted on social media; “As you guys know, I’m getting ready for a fight this Saturday against Lawler & my training is in full gear, which means workouts daily have only increased in intensity. My favorite thing to do after fights is use my CBD balm on all my joints, feet & hands. Once I tried CBD, I knew I had to make sure others knew about it too. That’s why I have joined the Cannafornia CBD team! Plants over pills baby, CBD has changed my life!”
Paul King, Cannafornia CEO, told reporters, “Our mission is to heal with plants instead of pills We all know someone who has overdosed or become dependent on doctor prescribed opioids. We’re fighting that battle with products produced from natural God-given plants. Colby is a pure athlete; an All-American Wrestler at Oregon State turned MMA Champion that is in the prime of his career, that needs the right supplements to keep his streak going. He is a humble person that understands marketing and will help tremendously to spread the message that CBD can replace opioids.”
The fighters favorite is the CBD Balm which contains 500 milligrams of CBD per jar. The hemp extract that is used in the balm does not produce the psychoactive effects associated with marijuana use, according to the World Health Organization. CBD, or cannabidiol, is one of the chemical compounds found in the cannabis plant that has grown in popularity in recent years for its perceived health benefits.
Cannafornia is a California based Cannabis company that ventured into CBD upon Trump’s passage of the Farm Bill in December 2018.
SOURCE CANNAFORNIA HOLDINGS INC
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis5 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE6 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis5 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt5 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis3 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III